PureTech Health (PRTC) Other Non-Current Assets (2019 - 2025)

PureTech Health (PRTC) reported Other Non-Current Assets of -$12.7 million for Q4 2025, down 150.84% year-over-year from $25.0 million in Q4 2024, and down 2770.95% on a QoQ basis from $475000.0 in Q2 2025.

PureTech Health (PRTC) has 7 years of Other Non-Current Assets data on file, last reported at -$12.7 million in Q4 2025.

  • Quarterly Other Non-Current Assets fell 150.84% year-over-year to -$12.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12.7 million (down 150.84% YoY) and the FY2025 annual result came in at -$12.7 million, down 150.84% from the prior year.
  • Other Non-Current Assets declined to -$12.7 million in Q4 2025 per PRTC's latest filing, from $475000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $47.0 million in Q4 2021 and bottomed at -$12.7 million in Q4 2025.
  • The 5-year median for Other Non-Current Assets is $13.5 million (2022), against an average of $15.1 million.
  • The widest annual swing landed in 2023, when Other Non-Current Assets soared 1262.05%; it then tumbled 150.84% in 2025.
  • Tracing PRTC's Other Non-Current Assets over 5 years: stood at $47.0 million in 2021, then plunged by 95.48% to $2.1 million in 2022, then soared by 1262.05% to $28.9 million in 2023, then declined by 13.75% to $25.0 million in 2024, then plunged by 150.84% to -$12.7 million in 2025.
  • Per Business Quant, the three latest PRTC Other Non-Current Assets figures stand at -$12.7 million (Q4 2025), $475000.0 (Q2 2025), and $25.0 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 60,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.26 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 2.13 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 63.55 Mn
10 PureTech Health 86.36 Mn -190.94 Mn - -12.69 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -12.69 Mn
Jun 30, 2025 475,000.00
Dec 31, 2024 24.95 Mn
Dec 31, 2023 28.93 Mn
Dec 31, 2022 2.12 Mn
Dec 31, 2021 47.02 Mn
Dec 31, 2020 45.48 Mn
Dec 31, 2019 2.12 Mn